Evidence map›Paper›PMID 25805752›Full record

ArticleThe Journal of infectious diseases2015

USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania.

Alphaxard Manjurano, Nuno Sepúlveda, Behzad Nadjm, George Mtove, Hannah Wangai, Caroline Maxwell, Raimos Olomi, Hugh Reyburn, Christopher J Drakeley, Eleanor M Riley and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Human genetic variations conferring resistance to malaria.Journal of translational medicine · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  12. Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Alphaxard ManjuranoJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi National Institute for Medical Research, Dar es Salaam, Tanzania.
Nuno SepúlvedaDepartments of Immunology and Infection Centre of Statistics and Applications, University of Lisbon, Portugal.
Behzad NadjmClinical Research.
George MtoveJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi National Institute for Medical Research, Dar es Salaam, Tanzania.
Hannah WangaiJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi.
Caroline MaxwellJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi.
Raimos OlomiJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi.
Hugh ReyburnJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi Departments of Immunology and Infection.
Christopher J DrakeleyJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi Departments of Immunology and Infection.
Eleanor M RileyJoint Malaria Programme, Kilimanjaro Christian Medical College, Moshi Departments of Immunology and Infection.
Taane G ClarkPathogen Molecular Biology Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom.
in Collaboration With MalariaGEN
Christian Medical College · INKilimanjaro Christian Medical Centre · TZChristian Medical College & Hospital · INClinical Research Management · USLondon School of Hygiene & Tropical Medicine · GBNational Institute for Medical Research · TZUniversity of Lisbon · PT

Funding

Medical Research Council MR/K000551/1Wellcome Trust 089276Wellcome Trust 090770/Z/09/ZWellcome Trust 091924Wellcome Trust WT077383/Z/05/Z
6 · The paper itself

Abstract

Populations exposed to Plasmodium falciparum infection develop genetic mechanisms of protection against severe malarial disease. Despite decades of genetic epidemiological research, the sickle cell trait (HbAS) sickle cell polymorphism, ABO blood group, and other hemoglobinopathies remain the few major determinants in severe malaria to be replicated across different African populations and study designs. Within a case-control study in a region of high transmission in Tanzania (n = 983), we investigated the role of 40 new loci identified in recent genome-wide studies. In 32 loci passing quality control procedures, we found polymorphisms in USP38, FREM3, SDC1, DDC, and LOC727982 genes to be putatively associated with differential susceptibility to severe malaria. Established candidates explained 7.4% of variation in severe malaria risk (HbAS polymorphism, 6.3%; α-thalassemia, 0.3%; ABO group, 0.3%; and glucose-6-phosphate dehydrogenase deficiency, 0.5%) and the new polymorphisms, another 4.3%. The regions encompassing the loci identified are promising targets for the design of future treatment and control interventions.

Indexed as

Polymorphism, GeneticABO Blood-Group SystemCarrier ProteinsCase-Control StudiesChildChild, PreschoolExtracellular Matrix ProteinsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeGlucosephosphate Dehydrogenase DeficiencyHaplotypesHemoglobin AHemoglobinopathiesHumansABO Blood-Group SystemCarrier ProteinsCCDC30 protein, humanExtracellular Matrix ProteinsFREM3 protein, humanHemoglobin ANerve Tissue ProteinsSDC1 protein, humanSyndecan-1Ubiquitin-Specific ProteasesUSP38 protein, humangenetic association studyhost susceptibilityPlasmodium falciparumsevere malariaTanzania

Identifiers

PMID25805752
PMCPMC4559194
OpenAlexW2120370984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.